Cruess, Alan; Zlateva, Gergana; Xu, Xiao; Soubrane, Gièle - In: PharmacoEconomics 26 (2008) 1, pp. 57-73
Bilateral NV-AMD imposes significant functional impairment on patients, leading to increased HRU and a high societal cost burden. Differences in national healthcare systems and NV-AMD treatment patterns were reflected in the wide variation of NV-AMD costs across the five surveyed countries. Even...